News
Mythic Therapeutics Backed by $103 Million in Series B Financing
Mythic Therapeutics announced its launch to develop smarter and safer antibody-drug conjugates (ADCs) with an oversubscribed Series B financing round of $103 million. The proceeds from Mythic’s Series B will finance the lead program through first-in-human clinical studies in lung cancer and fund pipeline development. (more)
Leuko Raises $5 Million Series A to Validate and Bring to Market Its Noninvasive White Blood Cell Monitoring Technology for Cancer Patients
Leuko, an MIT-born technology startup developing a non-invasive white blood cell monitoring device, raised $5 million Series A to validate and bring to market Its noninvasive white blood cell monitoring technology for cancer patients
Therini Bio Raises $36M Series A Financing
Funding from top-tier syndicate will be used to advance potential first-in-class investigational antibody THN391 into clinical trials. (more)
Aluna Announces Series B Financing
Aluna has raised almost $19 million in funding. Though a prescription is not required, Aluna recommends consulting with one’s physician when using the Aluna platform.
WIVI Vision and General Optica Join Forces
Announcing WIVI Vision’s new agreement with General Optica to include our technology in several of their shops. (more)
ABLE Organizes Focus Groups
The purpose of the focus groups was to gather experiences, insights, and suggestions from members of the ABLE community about how to best adapt an exoskeleton to home and community use. (more)
ADNTRO Highlights Advantages of the Best DNA Tests
The test that fully exploits the virtues of knowing our genetic code. It is the most complete and reliable test on the market. (more)
AtG Working to Stop Cancer Cells’ Resistance to Treatments
Oriol Casanovas and Gabriela Jiménez, AtG team, answer to the “Questions for the Future” of La Vanguardia newspaper. (more)
Newmanbrain Spin-off Winner of the In4Bankia Awards
The company has been awarded in the “Best Start-Up” category, aimed at firms with ideas to improve products or services based on new technologies. (more)